Vijayaragavan Muralidharan

3.5k total citations
123 papers, 2.4k citations indexed

About

Vijayaragavan Muralidharan is a scholar working on Surgery, Hepatology and Oncology. According to data from OpenAlex, Vijayaragavan Muralidharan has authored 123 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 56 papers in Surgery, 40 papers in Hepatology and 32 papers in Oncology. Recurrent topics in Vijayaragavan Muralidharan's work include Organ Transplantation Techniques and Outcomes (27 papers), Hepatocellular Carcinoma Treatment and Prognosis (22 papers) and Liver Disease and Transplantation (18 papers). Vijayaragavan Muralidharan is often cited by papers focused on Organ Transplantation Techniques and Outcomes (27 papers), Hepatocellular Carcinoma Treatment and Prognosis (22 papers) and Liver Disease and Transplantation (18 papers). Vijayaragavan Muralidharan collaborates with scholars based in Australia, United Kingdom and United States. Vijayaragavan Muralidharan's co-authors include Christopher Christophi, Mehrdad Nikfarjam, Cathy Malcontenti‐Wilson, Caterina Malcontenti‐Wilson, Michael Fink, Robert Jones, Graham Starkey, Robert M. Jones, Jaclyn Neo and Marcos V. Perini and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Annals of Surgery.

In The Last Decade

Vijayaragavan Muralidharan

120 papers receiving 2.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Vijayaragavan Muralidharan Australia 28 1.1k 663 590 564 371 123 2.4k
Paolo Dionigi Italy 26 1.1k 1.0× 394 0.6× 490 0.8× 457 0.8× 153 0.4× 132 2.6k
Mehrdad Nikfarjam Australia 33 1.4k 1.3× 423 0.6× 852 1.4× 1.5k 2.6× 372 1.0× 170 3.3k
Po‐Chin Liang Taiwan 26 648 0.6× 564 0.9× 308 0.5× 377 0.7× 201 0.5× 112 1.9k
Charles Cha United States 24 600 0.6× 707 1.1× 692 1.2× 973 1.7× 137 0.4× 79 2.5k
Lambros Tselikas France 24 818 0.8× 506 0.8× 705 1.2× 1.0k 1.8× 245 0.7× 116 2.6k
Yoshifumi Beck Japan 20 988 0.9× 989 1.5× 658 1.1× 534 0.9× 436 1.2× 87 2.1k
Hop S. Tran Cao United States 27 991 0.9× 255 0.4× 672 1.1× 1.4k 2.6× 317 0.9× 156 2.6k
Jörg Fuchs Germany 27 953 0.9× 403 0.6× 837 1.4× 518 0.9× 90 0.2× 171 3.0k
Pramod Rao France 27 755 0.7× 780 1.2× 656 1.1× 381 0.7× 209 0.6× 66 2.1k
Giammaria Fiorentini Italy 31 854 0.8× 1.1k 1.6× 803 1.4× 1.5k 2.6× 289 0.8× 140 2.9k

Countries citing papers authored by Vijayaragavan Muralidharan

Since Specialization
Citations

This map shows the geographic impact of Vijayaragavan Muralidharan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vijayaragavan Muralidharan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vijayaragavan Muralidharan more than expected).

Fields of papers citing papers by Vijayaragavan Muralidharan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vijayaragavan Muralidharan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vijayaragavan Muralidharan. The network helps show where Vijayaragavan Muralidharan may publish in the future.

Co-authorship network of co-authors of Vijayaragavan Muralidharan

This figure shows the co-authorship network connecting the top 25 collaborators of Vijayaragavan Muralidharan. A scholar is included among the top collaborators of Vijayaragavan Muralidharan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vijayaragavan Muralidharan. Vijayaragavan Muralidharan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
4.
Cortez, Alexander R., et al.. (2023). Impact of work hour restrictions on the operative experience of general surgical residents: A systematic review. SHILAP Revista de lepidopterología. 15. 100222–100222.
5.
Chapman, Brooke, Su Kah Goh, Frank Parker, et al.. (2022). Malnutrition and low muscle strength are independent predictors of clinical outcomes and healthcare costs after liver transplant. Clinical Nutrition ESPEN. 48. 210–219. 22 indexed citations
6.
Yoshino, Osamu, Daniel Cox, Eunice Lee, et al.. (2021). Elevated levels of circulating mitochondrial DNA predict early allograft dysfunction in patients following liver transplantation. Journal of Gastroenterology and Hepatology. 36(12). 3500–3507. 15 indexed citations
7.
8.
Perini, Marcos V., Laurence Weinberg, Michael Fink, et al.. (2021). Reduction in post‐operative pancreatic fistula with polyethylene glycol and recombinant human albumin sealant following stapled distal pancreatectomy. ANZ Journal of Surgery. 91(11). 2459–2465. 5 indexed citations
9.
Muralidharan, Vijayaragavan, Niall C. Tebbutt, Pok Fai Wong, et al.. (2020). Prevalence of hypoxia and correlation with glycolytic metabolism and angiogenic biomarkers in metastatic colorectal carcinoma. European Journal of Nuclear Medicine and Molecular Imaging. 48(5). 1585–1592. 4 indexed citations
10.
Fink, Michael, Marcos V. Perini, Laurence Weinberg, et al.. (2017). Age 80 years and over is not associated with increased morbidity and mortality following pancreaticoduodenectomy. ANZ Journal of Surgery. 88(5). E445–E450. 20 indexed citations
11.
Daruwalla, Jurstine, Khaled Greish, Cathy Malcontenti‐Wilson, et al.. (2015). Styrene maleic acid copolymer–pirarubicin induces tumor-selective oxidative stress and decreases tumor hypoxia as possible treatment of colorectal cancer liver metastases. Surgery. 158(1). 236–247. 2 indexed citations
12.
Ager, Eleanor I, et al.. (2014). Blockade of the renin–angiotensin system inhibits growth of colorectal cancer liver metastases in the regenerating liver. Clinical & Experimental Metastasis. 31(4). 395–405. 31 indexed citations
13.
Fifis, Theodora, Linh T. Nguyen, Cathy Malcontenti‐Wilson, et al.. (2013). Treatment with the vascular disruptive agent OXi4503 induces an immediate and widespread epithelial to mesenchymal transition in the surviving tumor. QUT ePrints (Queensland University of Technology). 1 indexed citations
14.
Muralidharan, Vijayaragavan, et al.. (2012). Prognostic Ability of 18F-FDG PET/CT in the Assessment of Colorectal Liver Metastases. Journal of Nuclear Medicine. 53(9). 1345–1351. 30 indexed citations
15.
Perini, Marcos V., et al.. (2012). Focal intrahepatic strictures: a review of diagnosis and management. HPB. 14(7). 425–434. 14 indexed citations
16.
Nikfarjam, Mehrdad, et al.. (2005). Patterns of heat shock protein (HSP70) expression and Kupffer cell activity following thermal ablation of liver and colorectal liver metastases. International Journal of Hyperthermia. 21(4). 319–332. 40 indexed citations
17.
Daruwalla, Jurstine, Mehrdad Nikfarjam, Cathy Malcontenti‐Wilson, Vijayaragavan Muralidharan, & Christopher Christophi. (2005). Effect of thalidomide on colorectal cancer liver metastases in CBA mice. Journal of Surgical Oncology. 91(2). 134–140. 10 indexed citations
18.
Nikfarjam, Mehrdad, Catriona McLean, Vijayaragavan Muralidharan, & Christopher Christophi. (2002). Neuroendocrine tumours of the ampulla of vater. ANZ Journal of Surgery. 72(7). 531–533. 5 indexed citations
19.
Muralidharan, Vijayaragavan & Christopher Christophi. (2001). Interstitial laser thermotherapy in the treatment of colorectal liver metastases. Journal of Surgical Oncology. 76(1). 73–81. 1 indexed citations
20.
Christophi, Christopher & Vijayaragavan Muralidharan. (2000). Accelerated tumour recurrence following percutaneous laser hyperthermia of colorectal liver metastases. HPB. 2(4). 383–388. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Paolo Dionigi Breakdown of academic impact, for papers by Mehrdad Nikfarjam Breakdown of academic impact, for papers by Po‐Chin Liang Breakdown of academic impact, for papers by Charles Cha Breakdown of academic impact, for papers by Lambros Tselikas Breakdown of academic impact, for papers by Yoshifumi Beck Breakdown of academic impact, for papers by Hop S. Tran Cao Breakdown of academic impact, for papers by Jörg Fuchs Breakdown of academic impact, for papers by Pramod Rao Breakdown of academic impact, for papers by Giammaria Fiorentini
Rankless by CCL
2026